These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33654016)

  • 1. Statins for treatment of chronic liver disease.
    Marrache MK; Rockey DC
    Curr Opin Gastroenterol; 2021 May; 37(3):200-207. PubMed ID: 33654016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects.
    Vargas JI; Arrese M; Shah VH; Arab JP
    Curr Gastroenterol Rep; 2017 Sep; 19(9):43. PubMed ID: 28752475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleiotropic effects of statins in the diseases of the liver.
    Janicko M; Drazilova S; Pella D; Fedacko J; Jarcuska P
    World J Gastroenterol; 2016 Jul; 22(27):6201-13. PubMed ID: 27468210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis.
    Kamal S; Khan MA; Seth A; Cholankeril G; Gupta D; Singh U; Kamal F; Howden CW; Stave C; Nair S; Satapathy SK; Ahmed A
    Am J Gastroenterol; 2017 Oct; 112(10):1495-1505. PubMed ID: 28585556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy.
    Muñoz AE; Pollarsky FD; Marino M; Cartier M; Vázquez H; Salgado P; Romero G
    World J Gastroenterol; 2021 Jul; 27(28):4639-4652. PubMed ID: 34366626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Statin for Hepatocellular Carcinoma Prevention Among Chronic Liver Disease Patients: A Systematic Review and Meta-analysis.
    Wong YJ; Qiu TY; Ng GK; Zheng Q; Teo EK
    J Clin Gastroenterol; 2021 Aug; 55(7):615-623. PubMed ID: 33606427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation.
    Kaplan DE; Mehta R; Garcia-Tsao G; Albrecht J; Aytaman A; Baffy G; Bajaj J; Hernaez R; Hunt K; Ioannou G; Johnson K; Kanwal F; Lee TH; Monto A; Pandya P; Schaubel D; Taddei TH
    Contemp Clin Trials; 2021 May; 104():106367. PubMed ID: 33771685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study.
    Thomson MJ; Serper M; Khungar V; Weiss LM; Trinh H; Firpi-Morell R; Roden M; Loomba R; Barritt AS; Gazis D; Mospan AR; Fried MW; Reddy KR; Lok AS
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):458-460.e4. PubMed ID: 33775894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins in liver disease: a molehill, an iceberg, or neither?
    Argo CK; Loria P; Caldwell SH; Lonardo A
    Hepatology; 2008 Aug; 48(2):662-9. PubMed ID: 18666246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES.
    Butt AA; Yan P; Bonilla H; Abou-Samra AB; Shaikh OS; Simon TG; Chung RT; Rogal SS;
    Hepatology; 2015 Aug; 62(2):365-74. PubMed ID: 25847403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy.
    Tzefos M; Olin JL
    J Clin Lipidol; 2011; 5(6):450-9. PubMed ID: 22108148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Safety and Benefit of Statins in Liver Cirrhosis: a Review.
    Souk K; Al-Badri M; Azar ST
    Exp Clin Endocrinol Diabetes; 2015 Nov; 123(10):577-80. PubMed ID: 26600051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis.
    Mohanty A; Tate JP; Garcia-Tsao G
    Gastroenterology; 2016 Feb; 150(2):430-40.e1. PubMed ID: 26484707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin Use in Patients With Chronic Liver Disease and Cirrhosis: Current Evidence and Future Directions.
    Kreidieh M; Hamadi R; Alsheikh M; Al Moussawi H; Deeb L
    Gastroenterology Res; 2022 Feb; 15(1):1-12. PubMed ID: 35369681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins in Hepatitis B or C Patients Is Associated With Reduced Hepatocellular Carcinoma Risk: A Systematic Review and Meta-Analysis.
    Li Z; Li Y; Li X; Zhang L; Zhao N; Du H; Zhou B; Ye Y
    Turk J Gastroenterol; 2022 Feb; 33(2):136-144. PubMed ID: 35115293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and the risks of decompensated liver cirrhosis and hepatocellular carcinoma determined in patients with alcohol use disorder.
    Chiu WC; Shan JC; Yang YH; Chen VC; Chen PC
    Drug Alcohol Depend; 2021 Nov; 228():109096. PubMed ID: 34600254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Meta-analysis of the effects of statins on the risk of chronic liver disease and hepatocellular carcinoma].
    Wei J; Lvy JH; Sun XJ; Wu XR
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jul; 29(7):696-701. PubMed ID: 34371542
    [No Abstract]   [Full Text] [Related]  

  • 19. Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis.
    Kim RG; Loomba R; Prokop LJ; Singh S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1521-1530.e8. PubMed ID: 28479502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of statins in patients with liver disease.
    Kalaitzakis E; Björnsson ES
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):15-24. PubMed ID: 24632765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.